Bioxytran, Inc.
BIXT
$0.03
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 463.00K | 509.90K | 14.50K | 3.10K | 4.30K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 3.60K | -- | -- | -- |
| Total Current Assets | 463.00K | 513.50K | 14.50K | 3.10K | 4.30K |
|
|
|||||
| Total Current Assets | 463.00K | 513.50K | 14.50K | 3.10K | 4.30K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 152.20K | 145.10K | 141.80K | 144.40K | 131.70K |
| Total Assets | 615.30K | 658.60K | 156.30K | 147.50K | 136.10K |
|
|
|||||
| Total Accounts Payable | 1.10M | 18.80K | 290.40K | -- | -- |
| Total Accrued Expenses | 832.90K | 1.48M | 855.50K | 711.70K | 563.50K |
| Short-term Debt | 1.21M | 1.25M | 1.40M | 1.35M | 1.26M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.86M | 501.60K | 518.60K | 725.80K | 1.02M |
| Total Other Current Liabilities | 1.86M | 501.60K | 518.60K | 725.80K | 1.02M |
| Total Current Liabilities | 5.01M | 3.25M | 3.06M | 2.78M | 2.84M |
|
|
|||||
| Total Current Liabilities | 5.01M | 3.25M | 3.06M | 2.78M | 2.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.21M | 1.25M | 1.40M | 1.35M | 1.26M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.01M | 3.25M | 3.06M | 2.78M | 2.84M |
|
|
|||||
| Common Stock & APIC | 18.68M | 18.41M | 17.56M | 17.56M | 17.52M |
| Retained Earnings | -23.11M | -21.04M | -20.52M | -20.24M | -20.27M |
| Treasury Stock & Other | -- | -- | 13.40K | -- | -- |
| Total Common Equity | -4.44M | -2.63M | -2.95M | -2.68M | -2.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 43.30K | 43.30K | 43.40K | 43.40K | 43.40K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 43.30K | 43.30K | 43.40K | 43.40K | 43.40K |
|
|
|||||
| Total Common Equity | -4.44M | -2.63M | -2.95M | -2.68M | -2.75M |
| Total Preferred Equity | 43.30K | 43.30K | 43.40K | 43.40K | 43.40K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.39M | -2.59M | -2.90M | -2.64M | -2.71M |
|
|
|||||